First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
Centre for Endocrine Surgery, Clinical Centre of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
J Surg Res. 2024 Jan;293:102-120. doi: 10.1016/j.jss.2023.08.020. Epub 2023 Sep 19.
The aim of this study was to determine the incidence and risk factors for hypothyroidism, both clinical and subclinical, following hemithyroidectomy in preoperatively euthyroid patients, as well as hypothyroidism remission and its time of remission.
A search was performed in Medline (via PubMed), Web of Science, and the Cochrane Library using the keywords "hemithyroidectomy + postoperative + hypothyroidism" and "hemithyroidectomy + hormone supplementation".
Fifty-four studies with a total of 9,999 patients were included. After a mean follow-up interval of 48.2 mo, the pooled hypothyroidism rate was 29%. The subclinical hypothyroidism rate was 79% of patients with hypothyroidism (18 studies). Moreover, a meta-analysis of 12 studies indicated a pooled hypothyroidism remission rate after hemithyroidectomy of 42% (95% CI: 24%-60%). Older patient age (MD = -2.54, 95% CI = -3.99, -1.10, P = 0.0006), female gender (OR = 0.69, 95% CI = 0.58, 0.82, P < 0.0001), higher preoperative thyroid-stimulating hormone levels (MD = -0,81, 95% CI = -0.96, -0.66, P < 0.00001), pathological preoperative anti-thyroid peroxidase antibodies (OR = 0.37, 95% CI = 0.24, 0.57, P < 0.00001) and anti-thyroglobulin antibodies (OR = 0.52, 95% CI = 0.36, 0.75, P = 00,005), and right-sided hemithyroidectomy (OR = 0.54, 95% CI = 0.43, 0.68, P < 0.00001) were associated with postoperative hypothyroidism development. In metaregression analysis, Asia presented a significantly higher hypothyroidism rate after hemithyroidectomy (34.6%, 95% CI = 29.3%-9.9%), compared to Europe (22.9%, 95% CI = 16.2%-29.5%, P = 0.037) and Canada (1.8%, 95% CI = -22.6%-26.2%, P = 0.013).
Hypothyroidism is a frequent and significant postoperative sequela of hemithyroidectomy, necessitating individualization of treatment strategy based on the underlying disease as well as the estimated risk of hypothyroidism and its risk factors.
本研究旨在确定在术前甲状腺功能正常的患者中,单侧甲状腺切除术后临床和亚临床甲状腺功能减退症的发生率和危险因素,以及甲状腺功能减退症的缓解及其缓解时间。
在 Medline(通过 PubMed)、Web of Science 和 Cochrane 图书馆中使用关键词“hemithyroidectomy + postoperative + hypothyroidism”和“hemithyroidectomy + hormone supplementation”进行了搜索。
共纳入 54 项研究,总计 9999 例患者。在平均 48.2 个月的随访间隔后,汇总的甲状腺功能减退症发生率为 29%。亚临床甲状腺功能减退症的发生率为甲状腺功能减退症患者的 79%(18 项研究)。此外,12 项研究的荟萃分析表明,单侧甲状腺切除术后甲状腺功能减退症的缓解率为 42%(95%CI:24%-60%)。年龄较大的患者(MD=-2.54,95%CI=-3.99,-1.10,P=0.0006)、女性(OR=0.69,95%CI=0.58,0.82,P<0.0001)、较高的术前促甲状腺激素水平(MD=-0.81,95%CI=-0.96,-0.66,P<0.00001)、术前病理性抗甲状腺过氧化物酶抗体(OR=0.37,95%CI=0.24,0.57,P<0.00001)和抗甲状腺球蛋白抗体(OR=0.52,95%CI=0.36,0.75,P=00,0.005)以及右侧甲状腺切除术(OR=0.54,95%CI=0.43,0.68,P<0.00001)与术后甲状腺功能减退症的发生相关。在荟萃回归分析中,亚洲单侧甲状腺切除术后甲状腺功能减退症的发生率明显高于欧洲(34.6%,95%CI=29.3%-9.9%)和加拿大(1.8%,95%CI=-22.6%-26.2%,P=0.013)(22.9%,95%CI=16.2%-29.5%,P=0.037)。
甲状腺功能减退症是单侧甲状腺切除术后常见且重要的后遗症,需要根据潜在疾病以及甲状腺功能减退症及其危险因素的估计风险来个体化治疗策略。